Back to search
Hyperalgesia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperalgesia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperalgesia trials you may qualify forThis study investigates whether MDMA may have a pain-reducing effect. The effect of MDMA is compared with a placebo (a substance with no active effect). In the…
The investigators propose to conduct a dose-escalation trial of an FDA-approved antiepileptic drug, lacosamide, added to opioid therapy in patients with chronic…
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyal…
Individuals with chronic pain are more likely to smoke cigarettes and have more difficulty quitting smoking than the general population, in part because withdra…
Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain i…
This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a lumbar media…
Chronic pain management is complex, with healthcare providers historically relying on prescribing opioid medications such as morphine. Although opioids may part…
Combination of guanfacine with opioid medication as a standard treatment for chronic pain.
Dual medication (guanfacine and morphine) as a standard treatment for chronic pain.